, ileal, and colic artery aneurysms ..........
Pancreaticoduodenal artery aneurysm
(PDAA) and gastroduodenal artery aneurysm
(GDAA) .............................................................................................
INTRODUCTION .........................................................................
METHODS .....................................................................................
Guideline framework .........................................................
Evidence synthesis ...............................................................
RENAL ARTERY ANEURYSM (RAA) ...............................
SPLENIC ARTERY ANEURYSM (SAA) ............................
CELIAC ARTERY ANEURYSM (CAA) ...............................
GASTRIC AND GASTROEPIPLOIC ARTERY
ANEURYSMS ...............................................................................
HEPATIC ARTERY ANEURYSM (HAA) ...........................
Hepatic artery pseudoaneurysm ..............................
True HAA .....................................................................................

3S
3S
4S
5S
6S
6S
7S
7S
8S
8S
9S
9S
10S
10S
14S
18S

SUPERIOR MESENTERIC ARTERY ANEURYSM
(SMAA) ...........................................................................................
JEJUNAL, ILEAL, AND COLIC ARTERY
ANEURYSMS ...............................................................................
PANCREATICODUODENAL ARTERY ANEURYSM
(PDAA) AND GASTRODUODENAL ARTERY
ANEURYSM (GDAA) ................................................................
REFERENCES .............................................................................

26S
27S
29S
33S

SUMMARY OF RECOMMENDATIONS

21S
23S
24S
24S

Renal artery aneurysm (RAA). 1.1: In patients who are
thought to have RAAs, we recommend computed
tomography angiography (CTA) as the diagnostic tool
of choice. Level of recommendation: Grade 1 (Strong),
Quality of Evidence: B (Moderate).
1.2: In patients who are thought to have RAA and have
increased radiation exposure risks or renal insufÔ¨Åciency,
we recommend non-contrast-enhanced magnetic resonance angiography (MRA) to establish the diagnosis.
Level of recommendation: Grade 1 (Strong), Quality of
Evidence: C (Low).

